A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Rapid Communications in Mass Spectrometry

• Publication date

  2008-04-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/rcm.3504PMID 18383206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering.

  2007cited by this paper
• Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry.

  2007cited by this paper
• Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60,000 in external calibration mode using an LTQ/Orbitrap.

  2007cited by this paper
• Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.

  2007cited by this paper
• Use of a trapping agent for simultaneous capturing and high-throughput screening of both "soft" and "hard" reactive metabolites.

  2007cited by this paper
• Drug-related hepatotoxicity.

  2006cited by this paper
• High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

  2006cited by this paper
• Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: Examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements

  2006cited by this paper
• Negative ion tandem mass spectrometry for the detection of glutathione conjugates.

  2005cited by this paper
• Genotoxicity screening: the slow march to the future

  2005cited by this paper
• Minimising the potential for metabolic activation in drug discovery

  2005cited by this paper
• Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.

  2005cited by this paper
• AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES

  2005cited by this paper
• Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  2005cited by this paper
• A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition.

  2005cited by this paper
• Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites.

  2005cited by this paper
• Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?

  2005cited by this paper
• Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature.

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• IN VITRO AND IN VIVO METABOLISM OF A POTENT AND SELECTIVE INTEGRIN v 3 ANTAGONIST IN RATS , DOGS , AND MONKEYS

  2004cited by this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cited by this paper
• In vitro and in vivo metabolism of a potent and selective integrin alpha v beta 3 antagonist in rats, dogs, and monkeys.

  2004cited by this paper
• Mechanistic studies on the bioactivation of diclofenac: identification of diclofenac-S-acyl-glutathione in vitro in incubations with rat and human hepatocytes.

  2003cited by this paper
• New perspectives in CNS safety pharmacology

  2002cited by this paper
• A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.

  2001cited by this paper
• Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).

  1999cited by this paper
• Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.

  1999cited by this paper
• AUTOMATED IDENTIFICATION OF ISOTOPICALLY LABELED PESTICIDES AND METABOLITES BY INTELLIGENT 'REAL TIME' LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY USING A BENCH-TOP ION TRAP MASS SPECTROMETER

  1998cited by this paper
• Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan.

  1997cited by this paper
• The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.

  1995cited by this paper
• The metabolism of alicyclic amines to reactive iminium ion intermediates

  1994cited by this paper
• Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4.

  1993cited by this paper
• Mass spectrometry in the analysis of glutathione conjugates.

  1993cited by this paper
• Fragmentation characteristic of glutathione conjugates activated by high-energy collisions

  1992cited by this paper

• Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity.

  2024cites this paper
• Discovery of Modified Metabolites, Secondary Metabolites, and Xenobiotics by Structure-Oriented LC-MS/MS.

  2023cites this paper
• Liquid Chromatography‐Mass Spectrometry (LC‐MS) Quantification of Reactive Metabolites

  2021cites this paper
• High-resolution mass spectrometry-based data acquisition and data-mining technologies for detecting and characterizing drug metabolites and traditional Chinese medicine components

  2020cites this paper
• Fundamentals and Advances of Orbitrap Mass Spectrometry

  2019cites this paper
• A high-throughput glutathione trapping assay with combined high sensitivity and specificity in high-resolution mass spectrometry by applying product ion extraction and data-dependent neutral loss.

  2019cites this paper
• Utilisation de la métabolomique pour l'étude de l'encéphalopathie hépatique et développement de nouvelles approches pour l'acquisition de données par spectrométrie de masse

  2019influential citation
• Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences.

  2018cites this paper
• Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften

  2018cites this paper
• Rapid screening and characterization of glutathione-trapped reactive metabolites using a polarity switch-based approach on a high-resolution quadrupole orbitrap mass spectrometer

  2018cites this paper
• Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: Where do we stand?

  2017cites this paper
• Trends in the application of high-resolution mass spectrometry for human biomonitoring: An analytical primer to studying the environmental chemical space of the human exposome.

  2017cites this paper
• Identification of flurochloridone metabolites in rat urine using liquid chromatography/high resolution mass spectrometry.

  2016cites this paper
• Improved data-dependent acquisition for untargeted metabolomics using gas-phase fractionation with staggered mass range.

  2015cites this paper
• Glutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts.

  2015cites this paper
• Emerging technologies, recent developments, and novel applications for drug metabolite identification.

  2015cites this paper
• Characterization of a highly sensitive and selective novel trapping reagent, stable isotope labeled glutathione ethyl ester, for the detection of reactive metabolites.

  2015cites this paper
• Detecting reactive drug metabolites for reducing the potential for drug toxicity

  2015cites this paper
• The role of drug metabolism in drug discovery and development : case ospemifene

  2015cites this paper
• Evolution of Orbitrap Mass Spectrometry Instrumentation.

  2015cites this paper
• Early Assessment of Exposure of Drug Metabolites in Humans Using Mass Spectrometry

  2014cites this paper
• Drug Metabolite Identification with High‐resolution Mass Spectrometry

  2014cites this paper
• Rapid screening and identification of target constituents using full scan-parent ions list-dynamic exclusion acquisition coupled to diagnostic product ions analysis on a hybrid LTQ-Orbitrap mass spectrometer.

  2014cites this paper
• High-resolution MS for drug metabolite identification

  2014cites this paper
• Improving natural products identification through targeted LC-MS/MS in an untargeted secondary metabolomics workflow.

  2014cites this paper
• Post-acquisition analysis of untargeted accurate mass quadrupole time-of-flight MS(E) data for multiple collision-induced neutral losses and fragment ions of glutathione conjugates.

  2014cites this paper
• In Vitro Experimental Models for Studying Drug Biotransformation

  2014cites this paper
• An integrated strategy for in vivo metabolite profiling using high-resolution mass spectrometry based data processing techniques.

  2013cites this paper
• Detection and characterization of ticlopidine conjugates in rat bile using high-resolution mass spectrometry: applications of various data acquisition and processing tools.

  2013cites this paper
• Metabolite structure analysis by high-resolution MS: supporting drug-development studies.

  2013cites this paper
• Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS.

  2013cites this paper
• A new strategy for the discovery of epimedium metabolites using high-performance liquid chromatography with high resolution mass spectrometry.

  2013cites this paper
• Application of exogenous mixture of glutathione and stable isotope labeled glutathione for trapping reactive metabolites in cryopreserved human hepatocytes. Detection of the glutathione conjugates using high resolution accurate mass spectrometry.

  2013cites this paper
• Resolving the microcosmos of complex samples: UPLC/travelling wave ion mobility separation high resolution mass spectrometry for the analysis of in vivo drug metabolism studies

  2013cites this paper
• Drug Metabolism in Drug Safety Evaluation

  2012cites this paper
• Enhanced detection and characterization of glutathione-trapped reactive metabolites by pseudo-MS(3) transition using a linear ion trap mass spectrometer.

  2012cites this paper
• The use of stable isotope labelling for the analytical chemistry of drugs.

  2012cites this paper
• Isotopic labeling of metabolites in drug discovery applications.

  2012cites this paper
• Simultaneous Screening of Glutathione and Cyanide Adducts Using Precursor Ion and Neutral Loss Scans-Dependent Product Ion Spectral Acquisition and Data Mining Tools

  2012cites this paper
• Time-of-Flight Mass Spectrometry Versus Orbitrap-Based Mass Spectrometry for the Screening and Identification of Drugs and Metabolites: Is There a Winner?

  2012cites this paper
• Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug‐Induced Liver and General Organ Toxicity

  2012cites this paper
• Application of Accurate Mass Spectrometry for Metabolite Identification

  2012cites this paper
• Hybrid Mass Analyzers in Drug Metabolism Applications

  2012cites this paper
• LC‐MS in Drug Metabolism and Pharmacokinetics: A Pharmaceutical Industry Perspective

  2012cites this paper
• Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites.

  2012cites this paper
• Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry*

  2011cites this paper
• Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.

  2011cites this paper
• Mass-defect filtering of isotope signatures to reveal the source of chlorinated palm oil contaminants

  2011cites this paper
• Evaluation of deuterium labeled and unlabeled bis-methyl glutathione combined with nanoliquid chromatography-mass spectrometry to screen and characterize reactive drug metabolites.

  2011cites this paper
• Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.

  2011cites this paper
• High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.

  2011cites this paper
• D-Isomer of gly-tyr-pro-cys-pro-his-pro peptide: a novel and sensitive in vitro trapping agent to detect reactive metabolites by electrospray mass spectrometry.

  2011cites this paper
• Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents

  2011cites this paper
• Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective

  2010cites this paper
• Experimental and computational investigation of affinity and selectivity factors in CYP2D6 and CYP3A4 mediated metabolism

  2010cites this paper
• Strategies for the Detection of Reactive Intermediates in Drug Discovery and Development

  2010cites this paper
• Experimental and computational investigation of affinity and selectivity factors in CYP 2 D 6 and CYP 3 A 4 mediated metabolism

  2010cites this paper
• Improved detection of reactive metabolites with a bromine-containing glutathione analog using mass defect and isotope pattern matching.

  2010cites this paper
• Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.

  2010cites this paper
• Thermo Scientific LTQ Orbitrap An Overview of the Scientific Literature

  2010cites this paper
• Application of Tandem Mass Spectra for the Peaks of Isotope Pattern in the Elemental Composition Assignment of Product Ions

  2010cites this paper
• Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.

  2010cites this paper
• Advances in structure elucidation of small molecules using mass spectrometry

  2010cites this paper
• Structural characterization of intact antibodies by high-resolution LTQ Orbitrap mass spectrometry.

  2009cites this paper
• Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.

  2009cites this paper
• Metabolism and Excretion of an Oral Taxane Analog, [C]3 -tert- Butyl-3 -N-tert-butyloxycarbonyl-4-deacetyl-3 -dephenyl-3 -N- debenzoyl-4-O-methoxy-paclitaxel (BMS-275183), in Rats and Dogs

  2009cites this paper
• Reactive Metabolite Screening and Covalent-Binding Assays

  2009cites this paper
• Analytical strategies for the screening and evaluation of chemically reactive drug metabolites

  2009cites this paper
• Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.

  2009cites this paper
• Rapid detection and characterization of in vitro and urinary N-acetyl-L-cysteine conjugates using quadrupole-linear ion trap mass spectrometry and polarity switching.

  2009cites this paper
• Analytical strategies for the screening and evaluation of chemically reactive drug metabolites.

  2009cites this paper
• Screening strategy for the rapid detection of in vitro generated glutathione conjugates using high-performance liquid chromatography and low-resolution mass spectrometry in combination with LightSight software for data processing.

  2009cites this paper
• Rapid screening and characterization of drug metabolites using multiple ion monitoring dependent product ion scan and postacquisition data mining on a hybrid triple quadrupole-linear ion trap mass spectrometer.

  2009cites this paper
• Advances in bioanalytical LC-MS using the Orbitrap™ mass analyzer.

  2009cites this paper
• Metabolite Identification Strategies and Procedures

  2009cites this paper
• Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations.

  2009cites this paper
• Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry.

  2009cites this paper
• An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.

  2009cites this paper
• Extracting metabolite ions out of a matrix background by combined mass defect, neutral loss and isotope filtration.

  2009cites this paper
• Metabolism and Excretion of an Oral Taxane Analog, [14C]3′-tert-Butyl-3′-N-tert-butyloxycarbonyl-4-deacetyl-3′-dephenyl-3′-N-debenzoyl-4-O-methoxy-paclitaxel (BMS-275183), in Rats and Dogs

  2009cites this paper
• Metabolite identification and profiling in drug design: current practice and future directions.

  2009cites this paper
• Liquid chromatography‐mass spectrometry in metabolite profiling

  2008cites this paper
• Orbitrap mass spectrometry: instrumentation, ion motion and applications.

  2008cites this paper